
Innoviva Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Innoviva Inc
Access all reports
Innoviva Inc. is a biopharmaceutical company focused on managing and developing royalty portfolios. The company's primary business involves the commercialization of its portfolio of royalties, primarily derived from partnerships with pharmaceutical companies. Innoviva's portfolio includes interests in respiratory medicines and other therapeutic areas, where it receives royalties from the sale of these products. The company is involved in actively managing its royalty portfolio and exploring potential acquisitions or partnerships to expand its interests in healthcare assets. The company is headquartered in Burlingame, California, and its shares are listed on the NASDAQ.
Latest articles
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
Ticker symbol
INVA
Country
🇺🇸 United States